Varaico: Literature-Extracted Genetic Variants

Gene:HEXA
Variant:p.E482K
Back to variants list

HEXA

NM_000520.6:p.E482K

Associated Papers

Genomic alterations in normal breast tissues preceding breast cancer diagnosis.

Dai J et al.

Breast Cancer Research : Bcr, 2025

40264151 (PubMed )
Supplement: 13058_2025_2018_MOESM1_ESM.xlsx › Table_S2

ALS Identified: two-year findings from a sponsored ALS genetic testing program.

Goutman SA et al.

Annals of Clinical and Translational Neurology, 2024

39044379 (PubMed )
Supplement: ACN3-11-2201-s003.xlsx › ClinGen_VariantClassification

Decoding Neurodegeneration: A Comprehensive Review of Molecular Mechanisms, Genetic Influences, and Therapeutic Innovations.

Voicu V et al.

International Journal of Molecular Sciences, 2023

Pontocerebellar atrophy is the hallmark neuroradiological finding in late-onset Tay-Sachs disease.

Májovská J et al.

Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology, 2022

In-silico screening and microsecond molecular dynamics simulations to identify single point mutations that destabilize β-hexosaminidase A causing Tay-Sachs disease.

Almanasra A et al.

Proteins, 2021

Genetic ancestry analysis on >93,000 individuals undergoing expanded carrier screening reveals limitations of ethnicity-based medical guidelines.

Kaseniit KE et al.

Genetics in Medicine : Official Journal of the American College of Medical Genetics, 2020

32595206 (PubMed )
Supplement: 41436_2020_869_MOESM2_ESM.xlsx › HEXA

In silico analysis of the effects of disease-associated mutations of β-hexosaminidase A in Tay-Sachs disease.

Ihsan Fazal M et al.

Journal of Genetics, 2020

Genotype-phenotype correlation of gangliosidosis mutations using in silico tools and homology modeling.

Ou L et al.

Molecular Genetics and Metabolism Reports, 2019

Tay-Sachs disease mutations in HEXA target the α chain of hexosaminidase A to endoplasmic reticulum-associated degradation.

Dersh D et al.

Molecular Biology of the Cell, 2016

Structural consequences of amino acid substitutions causing Tay-Sachs disease.

Ohno K et al.

Molecular Genetics and Metabolism, 2008

Evaluation of the risk for Tay-Sachs disease in individuals of French Canadian ancestry living in new England.

Martin DC et al.

Clinical Chemistry, 2007

Molecular analysis of the HEXA gene in Italian patients with infantile and late onset Tay-Sachs disease: detection of fourteen novel alleles.

Montalvo AL et al.

Human Mutation, 2005

Tay-Sachs screening in the Jewish Ashkenazi population: DNA testing is the preferred procedure.

Bach G et al.

American Journal of Medical Genetics, 2001

W474C amino acid substitution affects early processing of the alpha-subunit of beta-hexosaminidase A and is associated with subacute G(M2) gangliosidosis.

Petroulakis E et al.

Human Mutation, 1998

Tay-Sachs disease-causing mutations and neutral polymorphisms in the Hex A gene.

Myerowitz R

Human Mutation, 1997

Tay-Sachs disease and HEXA mutations among Moroccan Jews.

Kaufman M et al.

Human Mutation, 1997

Bacterial chitobiase structure provides insight into catalytic mechanism and the basis of Tay-Sachs disease.

Tews I et al.

Nature Structural Biology, 1996

Tay-Sachs disease screening and diagnosis: evolving technologies.

Hechtman P et al.

Dna and Cell Biology, 1993

Novel Tay-Sachs disease mutations from China.

Akalin N et al.

Human Mutation, 1992

Tay-Sachs disease in a Moroccan Jewish family: a possible new mutation.

Bach G et al.

Israel Journal of Medical Sciences, 1976

Select a paper to view details
UCSC Genome Browser·Imprint·Privacy·Terms·Feedback·Email Updates·

Regarding the variants extracted from papers and shown text snippets from research papers, the following holds: "Some rights reserved. This work permits non-commercial use, distribution and reproduction in any medium, provided the original author and source are credited."